Abstract
Therapy animals in hospital animal-assisted intervention programs are an invaluable part of holistic patient care. However, therapy dogs may be exposed to hospital-associated pathogens through these activities. This pilot study sought to examine the effect of topical chlorhexidine application, used as an infection control measure, on the microbial composition of the skin and mucous membranes of therapy dogs. We found that the chlorhexidine decolonization intervention altered microbial alpha diversity and shifted microbial structures in these therapy dogs, and particularly influenced more phylogenetically rare taxa. Specifically, the intervention reduced the abundance of Staphylococcus pseudintermedius, the archetypal canine commensal and a frequent cause of opportunistic infections. However, it did not reduce levels of S. aureus, which is a common hospital-associated pathogen of people. These preliminary findings highlight the importance of considering holistic microbial communities when undertaking infection control strategies, and stress the need for further research to understand the unintended consequences of antiseptic use on therapy dogs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding for this project was supported by the Morris Animal Foundation (D15CA-802) and the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development [5R01HD097692-02]. Funding for KRD is provided by a grant from the U.S. Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health to the Johns Hopkins Education and Research Center for Occupational Safety and Health [T42 OH0008428], and the AKC Canine Health Foundation Clinician-Scientist Fellowship 02525-E. MFD was supported by the National Institutes of Health (K01OD019918).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was given ethical approved by the Johns Hopkins University Bloomberg School of Public Health institutional review board, and Johns Hopkins University institutional animal care and use committee, prior to data collection. All therapy dog handlers and patients' parents provided written consent to participate in the study and approved having the findings published.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding Source: Funding for this project was supported by the Morris Animal Foundation (D15CA-802) and the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development [5R01HD097692-02]. Funding for KRD is provided by a grant from the U.S. Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health to the Johns Hopkins Education and Research Center for Occupational Safety and Health [T42 OH0008428], and the AKC Canine Health Foundation Clinician-Scientist Fellowship 02525-E. MFD was supported by the National Institutes of Health (K01OD019918).
Data Availability: The raw sequence data and metadata can be found in NCBI Sequence Read Archive (SRA) database under BioProject PRJNA695069, BioSample SAM17600695. Unix and R code used for analysis can be found under KRD’s Github repository: https://github.com/kathryndalton/AAT_pilot_analysis.
Data Availability
The raw sequence data and metadata can be found in NCBI Sequence Read Archive (SRA) database under BioProject PRJNA695069, BioSample SAM17600695. Unix and R code used for analysis can be found under KRD's Github repository: https://github.com/kathryndalton/AAT_pilot_analysis.
